Mei Hong

7.4k citations
134 papers · 5.7k indexed · 2 hit papers · h-index 34
Topics
Drug Transport and Resistance Mechanisms (33 papers)Trace Elements in Health (11 papers)Amino Acid Enzymes and Metabolism (11 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Mei Hong

130 papers receiving 5.6k citations

Hit Papers

TAK1 is a ubiquitin-dependent kinase of MKK and IKK20012026200920172001200450010001.5k

Peers

Mei Hong
Comparison fields: 5 of 134
  • Molecular Biology 2.8k
  • Cancer Research 1.7k
  • Immunology 1.6k
  • Oncology 1.2k
  • Epidemiology 443
Replace Masaru Yoshida with:
Masaru Yoshida Japan
Mark J. Arends United Kingdom
Francis Impens Belgium
Michael B. Fessler United States
Bernard Payrastre France
Sandip K. Basu United States
Domagoj Vucic United States
Paul Brennan United Kingdom
Henning R. Stennicke Denmark
Mei Hong relative to Masaru Yoshida Japan Masaru Yoshida's profile →
Citations per field
00.5×1.7×
Masaru Yoshida · 1×
Citations per year

Countries citing papers authored by Mei Hong

Since Specialization
Citations

This map shows the geographic impact of Mei Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Hong more than expected).

Fields of papers citing papers by Mei Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Hong. The network helps show where Mei Hong may publish in the future.

Co-authorship network of co-authors of Mei Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Hong. A scholar is included among the top collaborators of Mei Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Hong. Mei Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 2
6 1
7 7
8 2
9 1
10 4
11 5
12 38
13 19
14 19
15 12
16 10
17 13
18 134
19 36
20 62

About Mei Hong

Mei Hong is a scholar working on Biochemistry, Oncology and Cancer Research, having authored 134 papers that have together received 5.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (33 papers), Trace Elements in Health (11 papers) and Amino Acid Enzymes and Metabolism (11 papers). The work is most often cited by research in Cancer Research (1.7k citations), Immunology (1.6k citations) and Endocrinology (243 citations). Mei Hong has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zhijian J. Chen, Li Deng, Giridhar R. Akkaraju, Chen Wang, Jun‐ichiro Inoue, Shelley M. Payne, Abdullah Shaito, Yu‐Hsin Chiu, Lijun Sun and Rashu B. Seth. Their work appears in journals such as Nature, Journal of Biological Chemistry and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026